Patent drop today (WO2021041671) for $MRTX G12D KRAS inhibitor program - clinical candidate MRTX1133 possibly buried within.
From a med chem POV, certainly a lot of interesting functionality in leads, claiming sub-nM inhibition. Looking forward to the clinical data!